Platelet prophylaxis for haematological cancers

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET ONCOLOGY | 2013年 / 14卷 / 07期
关键词：
D O I：
10.1016/S1470-2045(13)70242-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E261 / E261
页数：1
相关论文
共 50 条
  • [41] HAEMATOLOGICAL CANCER Prophylactic platelet transfusion is frequently not necessary
    Schiffer, Charles A.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) : 431 - 432
  • [42] Is prophylactic platelet transfusion necessary in patients with haematological malignancies?
    Pinn, Stephen
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2013, 74 (01) : 11 - 11
  • [43] Compliance with prophylactic platelet transfusion trigger in haematological patients
    Eikenboom, JCJ
    van Wordragen, R
    Brand, A
    TRANSFUSION MEDICINE, 2005, 15 (01) : 45 - 48
  • [44] Research in haematological cancers: What do patients in the Netherlands prioritise?
    Scholvinck, Anne-Floor M.
    de Graaff, Bert M. B.
    van den Beld, Mechteld J.
    Broerse, Jacqueline E. W.
    EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (02)
  • [45] Devised performance as a tool for public engagement in acute haematological cancers
    Mermikides, A.
    Van de Velde, A.
    Mermikides, M.
    Tanczos, A.
    Law, R.
    Kirkham, A.
    Nasrat, A.
    Weitkamp, E.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5548 - 5549
  • [46] Changing causes of death in persons with haematological cancers 1975–2016
    Lezong Chen
    Yongqiang Zheng
    Kai Yu
    Shuzhao Chen
    Weida Wang
    Robert Peter Gale
    Ze-Xian Liu
    Yang Liang
    Leukemia, 2022, 36 : 1850 - 1860
  • [47] Haematological cancers in the breast and axilla: a drop in an ocean of breast malignancy
    Cox, J
    Lunt, L
    McLean, L
    BREAST, 2005, 14 (01): : 51 - 56
  • [48] Bioactive Phytoconstituents and Their Therapeutic Potentials in the Treatment of Haematological Cancers: A Review
    Iweala, Emeka J.
    Oluwapelumi, Adurosakin E.
    Dania, Omoremime E.
    Ugbogu, Eziuche Amadike
    LIFE-BASEL, 2023, 13 (07):
  • [49] Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers
    Schick, Markus
    Habringer, Stefan
    Nilsson, Jonas A.
    Keller, Ulrich
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (05) : 724 - 738
  • [50] Measurable residual disease (MRD)-testing in haematological and solid cancers
    Chen, Junren
    Gale, Robert Peter
    Hu, Yu
    Yan, Wen
    Wang, Tiantian
    Zhang, Wei
    LEUKEMIA, 2024, 38 (06) : 1202 - 1212
12345